Book contents
- CASE STUDIES Stahl’s Essential Psychopharmacology
- Reviews
- CASE STUDIES: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- List of icons
- Abbreviations
- Case 1: The salutatorian who couldn’t speak: selective serotonin reuptake inhibitor (SSRI)-refractory anxiety in an adolescent
- Case 2: From anxious to activated: selective serotonin reuptake inhibitor (SSRI)-related activation
- Case 3: The girl who couldn’t sleep: posttraumatic stress disorder (PTSD) in a young girl
- Case 4: Depressed and still depressed: major depressive disorder (MDD) in an adolescent
- Case 5: A 13-year-old adolescent who feels “amazing”: selective serotonin reuptake inhibitor (SSRI)-induced mania in an adolescent
- Case 6: Counting on a cure: obsessive compulsive disorder (OCD) in an adolescent
- Case 7: Struggles in the second grade: attention-deficit hyperactivity disorder (ADHD) in a child
- Case 8: From prodrome to psychosis: early-onset schizophrenia
- Case 9: Too much, too little, or just right? Lithium dosing in an adolescent
- Case 10: Tic, tic, tic: motor and vocal tics in a boy
- Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent
- Case 12: The adolescent who doesn’t eat: anorexia nervosa in an adolescent
- Case 13: High or higher antidepressant concentrations? Cannabis-related drug interactions in an adolescent
- Case 14: The boy whose bed was always wet: nocturnal enuresis in a child
- Case 15: Counting sheep and counting treatment trials: insomnia disorder in an adolescent
- Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD)
- Case 17: The “standard treatment” is earning a “D”: treatment-resistant schizophrenia
- Case 18: Symptoms, side effects, or both? Selective serotonin reuptake inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent
- Book part
- Case Studies Index
- Drugs Index
- References
Case 15: Counting sheep and counting treatment trials: insomnia disorder in an adolescent
Published online by Cambridge University Press: 09 February 2024
Book contents
- CASE STUDIES Stahl’s Essential Psychopharmacology
- Reviews
- CASE STUDIES: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- List of icons
- Abbreviations
- Case 1: The salutatorian who couldn’t speak: selective serotonin reuptake inhibitor (SSRI)-refractory anxiety in an adolescent
- Case 2: From anxious to activated: selective serotonin reuptake inhibitor (SSRI)-related activation
- Case 3: The girl who couldn’t sleep: posttraumatic stress disorder (PTSD) in a young girl
- Case 4: Depressed and still depressed: major depressive disorder (MDD) in an adolescent
- Case 5: A 13-year-old adolescent who feels “amazing”: selective serotonin reuptake inhibitor (SSRI)-induced mania in an adolescent
- Case 6: Counting on a cure: obsessive compulsive disorder (OCD) in an adolescent
- Case 7: Struggles in the second grade: attention-deficit hyperactivity disorder (ADHD) in a child
- Case 8: From prodrome to psychosis: early-onset schizophrenia
- Case 9: Too much, too little, or just right? Lithium dosing in an adolescent
- Case 10: Tic, tic, tic: motor and vocal tics in a boy
- Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent
- Case 12: The adolescent who doesn’t eat: anorexia nervosa in an adolescent
- Case 13: High or higher antidepressant concentrations? Cannabis-related drug interactions in an adolescent
- Case 14: The boy whose bed was always wet: nocturnal enuresis in a child
- Case 15: Counting sheep and counting treatment trials: insomnia disorder in an adolescent
- Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD)
- Case 17: The “standard treatment” is earning a “D”: treatment-resistant schizophrenia
- Case 18: Symptoms, side effects, or both? Selective serotonin reuptake inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent
- Book part
- Case Studies Index
- Drugs Index
- References
Summary
Which of the following may be chronotropically dosed to re-entrain circadian rhythms?
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential PsychopharmacologyChildren and Adolescents, pp. 233 - 258Publisher: Cambridge University PressPrint publication year: 2023
References
Alfano, C. A., Ginsburg, G. S., Kingery, J. N. Sleep-related problems among children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007; 46: 224–32. https://doi.org/10.1097/01.chi.0000242233.06011.8eCrossRefGoogle ScholarPubMed
Brent, D., Emslie, G., Clarke, G., et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008; 299(8): 901–13. https://doi.org/10.1001/jama.299.8.901Google Scholar
de Zambotti, M., Goldstone, A., Colrain, I. M., Baker, F. C. Insomnia disorder in adolescence: diagnosis, impact, and treatment. Sleep Med Rev 2018; 39: 12–24. https://doi.org/10.1016/j.smrv.2017.06.009Google Scholar
Skoch, S. H., Mills, J. A., Ramsey, L., Strawn, J. R. Letter to the editor: sleep disturbances in selective serotonin reuptake inhibitor-treated youth with anxiety disorders and obsessive compulsive disorder: a Bayesian hierarchical modeling meta-analysis. J Child Adolesc Psychopharmacol 2021; 31(5): 387–88. https://doi.org/10.1089/cap.2020.0169Google Scholar
Malow, B. A., Findling, R. L., Schroder, C. M., et al. Sleep, growth, and puberty after 2 years of prolonged-release melatonin in children with autism spectrum disorder. J Am Acad Child Adolescent Psychiatry 2021; 60(2): 252–61.e3. https://doi.org/10.1016/j.jaac.2019.12.007Google Scholar
Orbeta, R. L., Overpeck, M. D., Ramcharran, D., Kogan, M. D., Ledsky, R. High caffeine intake in adolescents: associations with difficulty sleeping and feeling tired in the morning. J Adolesc Health 2006; 38(4): 451–53. https://doi.org/10.1016/j.jadohealth.2005.05.014CrossRefGoogle ScholarPubMed
Owens, J. A., Dalzell, V. Use of the “BEARS” sleep screening tool in a pediatric residents’ continuity clinic: a pilot study. Sleep Med 2005; 6(1): 63–69. https://doi.org/10.1016/j.sleep.2004.07.015Google Scholar
Owens, J. A., Mindell, J., Baylor, A. Effect of energy drink and caffeinated beverage consumption on sleep, mood, and performance in children and adolescents. Nutrition Reviews 2014; 72(S1): 75–61. https://doi.org/10.1111/nure.12150CrossRefGoogle ScholarPubMed
Owens, J. A., Rosen, C. L., Mindell, J. A., Kirchner, H. L. Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey. Sleep Med 2010; 11(7): 692–700. https://doi.org/10.1016/j.sleep.2009.11.015Google Scholar
Owens, J. A., Spirito, A., McGuinn, M. The Children’s Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep 2000; 23(8): 1–9. https://doi.org/10.1093/sleep/23.8.1dGoogle Scholar
Russo, R. M., Gururaj, V. J., Allen, J. E. The effectiveness of diphenhydramine HCl in pediatric sleep disorders. J Clin Pharmacol 1976; 16(5–6): 284–88. https://doi.org/10.1002/j.1552-4604.1976.tb02406.xGoogle Scholar
Schroder, C. M., Malow, B. A., Maras, A., et al. Pediatric prolonged-release melatonin for sleep in children with autism spectrum disorder: impact on child behavior and caregiver’s quality of life. J Autism Develop Disord 2019; 49(8): 3218–30. https://doi.org/10.1007/s10803-019-04046-5Google Scholar
Shamseddeen, W., Clarke, G., Keller, M. B., et al. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study. J Child Adolesc Psychopharmacol 2012; 22(1): 29–36. https://doi.org/10.1089/cap.2011.0027Google Scholar
Skoch, S. H. Pediatric insomnia: treatment. Curr Psychiatry 2022; 21(1): 15–21. https://doi.org/10.12788/cp.0200Google Scholar
van Geijlswijk, I. M., Mol, R. H., Egberts, T. C. G., Smits, M. G. Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia. Psychopharmacology 2011; 216(1): 111–20. https://doi.org/10.1007/s00213-011-2202-yGoogle Scholar
van Geijlswijk, I. M., van der Heijden, K. B., Egberts, A. C. G., Korzilius, H. P. L. M., Smits, M. G. Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. Psychopharmacology 2010; 212(3): 379–91. https://doi.org/10.1007/s00213-010-1962-0Google Scholar
Weiss, S. K., Garbutt, A. Pharmacotherapy in pediatric sleep disorders. In Sass, A. E., Kaplan, D. W. (eds.), Adolescent Medicine: State of the Art Reviews. Itasca, IL: American Academy of Pediatrics, 2005. https://doi.org/10.1542/9781581105803-pharmacotherapyGoogle Scholar